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1. Introduction and objectives of the doctoral thesis 
Cardiovascular diseases and malignant tumors are the leading 
cause of death, worldwide. Based on the hungarian statistical data the most 
common cardiovascular diseases are the ischemic injuries of the heart and 
the acute heart tissue necrosis. Main risk factors of these disorders include, 
inter alia, high blood pressure, dyslipidemia, diabetes mellitus, obesity, 
smoking and severe non influenced factors, for example age and familiar 
clustering. 
It is very important to emphasize the importance of prevention in 
relation to any diseases, however not every disorders can be prevented, but 
the delay is extremly important. 
In relation to dietary supplements as part of prevention, we have to 
talk about the complex healthy lifestyle, which includes healthy diet, 
exercise and mental balance. People of today have to adapt to the course of 
time evolved life. I think it is important to insert the exercise into the hectic 
everyday life, manage the stress and especially replace and compliment the 
vitamins, minerals, trace elements and fibers. The most efficient means of 
this are the dietary supplements. In case of these supplements quality, 
proper fromulation, price and marketing are very important factors. 
It can be said, that we live the age of nutrients, which is featured by 
overuse and selection and taking non proper and harmful preparations. 
Hugh amount of materials with natural origin can be found in pharmacies, 
drogeries and on the internet, which are used without appropriate scientific 
data.  
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I In the first part of our experiments we determined the effects of 
sour cherry seed kernel extract treatment on hepatic and renal 
function and toxicity. In further experiment we studied the direct 
effect on seed kernel oil on the skin and the photoprotective effect 
of oil containing creams. 
II   In the second part of our experiments we investigated the effects 
of long term, low and high dose beta-carotene treatment on heart 
function, infact size, tissue antioxidant capacity and HO-1 level. In 
further experiments we measured the cytotoxic effect of beta-
carotene treatment on H9c2 cell line by MTT assay.  
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2. Materials and methods 
Analysis of sour cherry seed kernel extract toxicity 
Seed extracts 
The dosage of sour cherry seed extract (SCSE) was used as the 
primary independent variable in the present study. Sour cherry seeds were 
dried, and the wall was removed. The kernels were then macerated into a 
paste with a consistency suitable for administration to animals via gavage. 
This SCSE was prepared so as to contain both the oil and bioflavone rich 
solid fractions of the kernel. High pressure compressed seed kernel oil was 
used for the dermal studies. 
Animals 
Mice used for organ toxicity and blood biomarker experiments were strain 
C57BL/6J males with an average weight of 32 ± 4 g. Male Hartley guinea 
pigs weighing 250–350 g were used for evaluation of dermal effects. The 
animals were fed regular rodent chow ad libitum with free access to water. 
The animals were allowed 1 week to acclimatize before the experiments and 
were kept at 25 ± 2 °C, with a relative humidity of 55 ± 5 % and a 12 h 
light–dark cycle. All animals included in the present study were handled 
and received humane care in compliance with the principles of the 
laboratory animal care formulated by the National Society for Medical 
Research and Guide for the Care and Use of Laboratory Animals prepared 
by the National Academy of Sciences and published by the National 
Institutes of Health (Publication No. NIH 85–23, revised, 1996). All 
protocols for use in this investigation were approved by the institutional 
review board (IRB) of University of Debrecen, Hungary. 
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SCSE dosage groups 
The mice were randomly assigned to six test groups based on 
SCSE dosage, members of which were administered whole kernel meal 
once daily by gavage for 8 days in dosages in the range 0–3000 mg/kg, 
defined as follows: Group I: no SCSE, the negative control group, gavaged 
with normal saline buffer only (n = 7); Group II: 250 mg/kg SCSE (n = 7); 
Group III: 500 mg/kg SCSE (n = 8); Group IV: 1000 mg/kg SCSE (n = 8); 
Group V: 3000 mg/kg SCSE (n = 6). 
Oral toxicity assessments 
Oral administration of SCSE by gavage was conducted to assess 
hepatic and nephrotoxicity of the seed kernel contents. After completion of 
the SCSE treatment regimen, the animals were anesthetized with sodium 
pentobarbital (80 mg/kg, i.p.) and sacrificed under deep anesthesia, 
followed by measurement of the body weight of each mouse. The livers and 
kidneys were excised immediately after collection of blood, weighed, 
washed in ice cold saline and stored in PBS with 10% formalin. The 
following postmortem evaluations were then conducted. 
Macroscopic examination 
All mice were given a complete postmortem examination 
(autopsy). The abdominal, thoracic and cranial cavities were examined for 
abnormalities, and the organs were removed, examined and fixed in 10% 
formalin. Weights of kidney and liver were recorded and organ weight 
ratios were calculated relative to total body weights. 
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Serum metabolites and enzyme activities 
Test kits purchased from Asan Pharmaceutical (Seoul, Korea) were 
used to determine the occurrence of toxic effects on kidney or liver function 
by assessment of biomarkers in mouse blood. The blood samples were left 
to stand at room temperature for 1 hour and then centrifuged at 300 × g for 
10 min to obtain the serum. Serum blood urea nitrogen and creatinine levels 
were assessed as indicators of the kidney function. Serum glutamic 
oxaloacetic transaminase activity, serum glutamic pyruvic transaminase 
activity and serum alkaline phosphatase, were measured as indicators of 
liver function. 
Histopathological/microscopic examination 
Blood collected from the jugular veins was utilized for serum 
preparation. The mice were then sacrificed, followed by removal of liver 
and kidneys and fixation of these organs in 10% formalin solution, from 
which 5 μm thick histological sections were prepared. Tissue specimens 
were hematoxylin–eosin (HE) stained and observed under a light 
microscope.  
Dermal responses to SCSE oil fraction 
Experiments were conducted in which the kernel oil fraction was 
applied topically to shaved skin of animals to evaluate possible adverse skin 
responses, and also to demonstrate the photoprotective ability of the oil. 
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Dermal toxicity studies 
The capacity of the sour cherry kernel oil to act as an allergen or 
otherwise damage the skin was evaluated. Guinea pigs were anesthetized 
with intraperitoneal pentobarbital sodium (30 mg/kg body weight). After 
anesthesia, the hair on the back was closely shaved followed by epilation of 
remaining micro hair. Dosages of 0, 1, 2, 3 and 5 µl of the kernel oil was 
massaged into the epilated skin of five animals. Distilled water was applied 
to the skin of a control group of guinea pigs (n = 5). Initially, animals were 
monitored hourly and then, after every 12 h for 21 days. 
Photoprotection/phototoxicity studies 
The capacity of the oil to protect skin from the effects of ultraviolet 
radiation was evaluated. Here, five guinea pigs were closely shaved and 
covered with aluminum foil into which five rectangular slots had been cut. 
Next, SCSE oil in unguent was applied to the skin under each slot at 
dosages of 0–5% by weight of the kernel oil. The animals were placed 
under UVB apparatus and the uncovered skin was irradiated for 40 min. 
Evaluations of UVB induced skin damage and the protective effect of the 
SCSE oil were made 6 h after irradiation. Here, the dermal allergic response 
and phototoxicity experiments were conducted as stand alone studies 
independently demonstrating aspects of interaction between skin and the 
kernel oil fraction with relevance to possible human topical use. No 
correlations between the dermal and oral studies were deemed necessary for 
validation of outcomes described in the present report, or their potential 
relevance to the clinical benefits of SCSE. 
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Statistical methods 
SPSS statistical analysis software was used. The date were 
compared by Student’s t-test in assessment of the significance (p) value for 
differences between test groups versus negative control animals with 
respect to enzyme activities and organ weight ratios. For all comparisons, a 
value of p<0.05 was considered the threshold for significant difference 
between magnitude of a particular outcome variable in a test group versus 
the corresponding control group value. 
 
The cardiovascular effects of beta-carotene  
Animals 
 The experiments were accomplished using adult male rats (Charles 
River Laboratories), with a body weight range of 350–400 g. All animals 
received humane care in compliance with the “Principles of Laboratory 
Animal Care” (formulated by the U.S. National Society for Medical 
Research, as described in U.S. National Institutes of Health publication No. 
86-23, revised 1996) and the “Guide for the Care and Use of Laboratory 
Animals”. Maintenance and treatment of animals used in the present study 
was additionally approved by the „Institutional animal care and use 
committee of the University of Debrecen”, Debrecen, Hungary. The animals 
were housed in wire-bottomed cages (three rats per cage) throughout the 
study and were maintained on a 12:12-h light–dark cycle; and provided with 
laboratory rodent chow pellets, and water ad libitum. 
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Groups and administration of beta-carotene  
 Rats used in the present study were segregated into 3 groups and 
gavage-administered the following agents: hydroxyethyl cellulose-water 
(1:4) vehicle control (C); LD–BC (30 mg/kg/day) and HD–BC (150 
mg/kg/day) suspended in hydroxyethyl cellulose-water, respectively. BC 
was obtained from Sigma–Aldrich Kft. 
Ischemia-reperfusion and isolated working hearts  
 Following 4-week treatment with vehicle or BC, the rats were 
anesthetized with intraperitoneal injections of ketamine-xylazine (75/10 
mg/kg), with heparin anticoagulant administered intraperitoneally (1000 
IU/kg). After thoracotomy, the hearts were excised and placed in ice-cold 
modified Krebs-Henseleit bicarbonate buffer (118.5 NaCl, 4.7 KCl, 2.5 
CaCl2 × H2O, 25 NaHCO3, 1.2 KH2PO4, 1.2 MgSO4, and 10.0 glucose (in 
mM)), then cannulated through the aorta and perfused in a Langendorff 
“non-working” mode (100 cm of water) for 5 min to flush blood out from 
the hearts. Subsequently, ’’working” perfusion was conducted using a 
cannulated pulmonary vein, during which the isolated heart preparatum was 
switched to working mode (at a filling pressure of 17 cm of the buffer). 
After 10 min of working perfusion, 30 min of global ischemia (ISA) was 
initiated for each procedure, by clamping the pulmonary inflow and the 
aortic outflow. At the end of the ischemic period, 120 min of reperfusion 
(REP) was initiated by unclamping the inflow and outflow lines. The first 
10 min of REP was conducted in Langendorff mode to avoid the fatal 
ventricular arrhythmias. 
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Cardiac function measurements  
 Baseline assessment of cardiac function for each isolated heart was 
made following 10 min of working perfusion. To examine the recovery of 
the left ventricle, these parameters were measured after 30, 60, and 120 min 
of REP. Cardiac function evaluation for each experiment was conducted 
described here. Briefly, heart rate (HR) was measured using a computer 
acquisition system (ADInstruments, PowerLab, Castle Hill, Australia); 
coronary flow (CF) values were obtained by timed collection of effluent 
dripping from each heart; aortic flow (AF) measurements were made using 
a calibrated flow meter; cardiac output (CO) was generated as the sum of 
AF and CF. Stroke volume (SV) was calculated as the quotient of CO/HR; 
and alteration in SV values, as a function of treatments, were calculated as 
the ratio of SV at reperfusion divided by baseline SV and multiplied by 100. 
Infarct size determination  
 Estimations of infarct size (IS) were conducted using the triphenyl 
tetrazolium chloride (TTC) staining method. Briefly, following each 30-min 
ISA/120-min REP period, hearts were perfused with 50 ml 1% (w/v) 
solution of TTC in phosphate buffer (pH 7.4), and the samples were stored 
at −70 ◦C for subsequent analysis. The frozen samples were sectioned, 
weighted, and blotted dry. The dried sections were scanned on an Epson 
J232D flat-bed scanner. The infarcted area and the risk area were measured 
using planimetry software (Image J, National Institute of Health, Bethesda, 
Maryland, USA). Estimates of infarcted zone magnitude were subsequently 
obtained by multiplying infarcted areas by weight of each slice. The 
resulting numbers represent weight of the risk zone and the infarcted zone. 
12 
 
Infarct size was expressed as percentage of the weight of infarcted tissue 
and the weight of risk zone (whole heart).  
Western blot analysis of heart tissue  
 Content of HO-1 protein in the myocardium were obtained by 
Western blot. Approximately 300 mg of left ventricular myocardial tissue 
were homogenized on ice using a tissue homogenizer (IKA T10 basic 
ULTRA-TURRAX®) in isolating buffer (25 mM Tris–HCl, 25 mM NaCl, 1 
mM ortho-vanadate, 10 mM NaF, 10 mM pyrophosphate, 10 mM okadaic 
acid, 0.5 mM EDTA, 1 mM PMSF, and 1 × protease inhibitor cocktail) and 
centrifuged at 2000 rpm at 4 
◦
C for 10 min. The supernatants were 
transferred to fresh tubes and centrifuged at 10,000 rpm at 4 
◦
C for 20 min, 
after which the resulting supernatant was used as cytosolic fraction. The 
protein concentration was measured by ND-1000 Nano drop 
spectrophotometer with BCA Protein Assay Kit (Thermo Scientific, 
Rockford, IL). Thirty µg of protein in each sample were loaded in 10% 
polyacrylamide gel and resolved using SDS-PAGE electrophoresis and then 
transferred to 0.45 µm pore size nitrocellulose membrane to concentrate the 
samples. After blocking the membranes with 7% nonfat dry milk in TBST, 
membranes were incubated overnight with primary antibody solution in 1% 
of nonfat dry milk in TBST (GAPDH 1/40000, antibody was obtained from 
Cell Signaling Technology, Boston, MA; and HO-1 1/50 was ordered from 
Sigma–Aldrich Kft. Budapest, Hungary) at 4 ◦C. Then, the membranes were 
washed 3 times, each for 10 min, in TBST and incubated with horseradish 
peroxidase-conjugated secondary antibody solution (Cell Signaling 
Technology) containing 1% of nonfat dry milk in TBST, for 2 h at room 
temperature. The membranes were treated with Western blot Enhanced 
13 
 
Chemiluminescent HRP substrate (Millipore, Billerica, MA) to visualize the 
bands. After the enhanced chemiluminescent treatment, the membranes 
were exposed on X-ray films (Agfa, Mortsel, Belgium). The films were then 
digitalized by flat-bed scanner (Epson J232D) and analyzed using ImageJ 
program and normalized the HO-1 band intensities to GAPDH. 
MTT cell viability assays for beta-carotene cytotoxicity 
  Evaluation of BC cytotoxicity on cellular survival was 
accomplished using the 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT). H9c2 cells (ATCC, CRL-1446, LGC 
Standards GmbH, Wesel Germany) dissociated by trituration in medium 
(Dulbecco’s modified eagle’s medium from Sigma with 10% FBS, 1% 
penicillin-streptomycin). Cells were seeded into 96 well plates at a density 
of 3000 cells/well and cultured for 1 day to establish adhesion of the wells. 
Cells were treated with 0, 2.5, 5, 10 and 20 µM BC for 4 h, respectively. 
Next, following a 30-min incubation period, half of the wells were treated 
with 125 µM H2O2. Four hours later, addition of 20 µl MTT solution (5 
mg/ml in PBS) to each well and an additional 3 h incubation at 37 ◦C to 
allow mitochondrial uptake, the medium was removed and cells were lysed 
by addition of 150 µl of isopropanol, incubated for 15 min followed by 
measurement of absorbance at 570 and 690 nm using a plate reader 
(FLUOstar OPTIMA, BMG Labtech). Within each experiment, absorbance 
values were averaged across 4 replicate wells and repeated 3 times. BC 
cytotoxic effect assessments were estimated based on linear correlation of 
absorbance values with MTT-associated H9c2 viability and reported as 
percentage of cells surviving 4 h of BC exposure relative to control cells not 
exposed to BC. 
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Tissue antioxidant capacity (TAC)  
 TAC of heart tissue was measured using the CS0790-1KT antiox-
idant assay kit (Sigma–Aldrich Kft., BP., Hungary). Briefly, at the end of 
reperfusion, the hearts were frozen and stored at −70 ◦C until analysis. 
Approximately, 100 mg of left ventricular myocardial tissue from each 
heart were homogenized in 0.5 ml of 1 × assay buffer, centrifuged at 12,000 
rpm, for 15 min at 4 ◦C and the supernatants collected for assay. Following 
sample preparation according to manufacturer’s instructions, the absorbance 
was measured at 405 nm using a plate reader (FLUOstar OPTIMA, BMG 
Labtech). TAC values for each heart were derived from absorbance values 
and expressed as Trolox equivalent (µM). 
Statistical analysis 
 Statistical analyses were performed using GraphPad Prism 5 
software. The data are expressed as mean ± SEM. One-way ANOVA 
followed by Bonferroni post-test was carried out for heart function data 
analysis. MTT data were compared by t-test. For Western blot and TAC 
data outcomes, repeated measures of one-way ANOVA followed by 
Tukey’s post-test was conducted. Differences were considered significant at 
values of p<0.05. 
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3. New scientific results of the thesis 
 Results of sour cherry seed kernel extract experiments  
Macroscopic observations 
 Macroscopic evaluations of the animals failed to demonstrate gross 
anatomical abnormalities or other visible pathological changes. 
Examination of brain, eyes, heart, lung, liver, pancreas, spleen, 
gastrointestinal tract, kidney, urinary tract, genital tract, skeletal muscle and 
skin in test animals revealed no differences from the corresponding organs 
in the negative control group.  
Results of serum metabolite and enzyme activity experiments  
 For each variable evaluated, no significant differences in outcome 
were observed when the SCSE‐treated animals were compared with the 
normal saline‐treated negative control group. Moreover no significant 
differences were noted when outcomes were compared between dosage 
groups.  
Results of tissue pathology experiments  
Histopathological observation of kidney  
 Hematoxylin‐eosin (HE)‐stained, 40 μm tissue sections taken from 
the medullar region of each kidney were examined for changes in tissue 
ultrastructure that may indicate toxic effects. Urinary and blood vessels, and 
malpighian corpuscles were visible and seen to be normal in the 
representative image selected from kidneys taken from the control animals 
gavaged with normal saline and those treated with 250, 500 and 1000 and 
mg/kg SCSE. Conversely, images of kidneys taken from animals gavaged 
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with 3000 mg/kg SCSE show congestion of blood and urinary vessels and 
changes in tissue microstructure suggestive of inflammatory damage.  
Histopathological observation of liver  
 Structural features examined included hepatocytes, hepatic cords, 
sinusoids and the structure as a whole. No abnormalities were observed in 
any of the dosage groups and liver tissue appeared morphologically intact 
throughout the dosage range.  
Results of sour cherry seed kernel oil experiments 
Dermal toxicity studies 
 Comparison of test and control animals revealed that the skin of 
guinea pigs receiving dermal applications of various doses of seed kernel oil 
was not different from the skin of animals administered distilled water. 
After 21 days, none of the test animals exhibited adverse changes to the skin 
suggestive of an allergic or otherwise toxic reaction to contact with the oil. 
Effect of sour cherry seed kernel oil effect on UV radiation induced 
skin damage  
 The result of experiments assessing the capacity of the kernel oil to 
inhibit UV phototoxicity. Unprotected skin irradiated with UVB for 40 min 
exhibited significant erythema 2 h after irradiation was halted, with 
maximal skin effects observed after 6 h. Creams containing kernel oil at a 
dosage of 3 % or greater provided significant protection against UV 
damage. 
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Results of beta-carotene experiments  
Effects of beta-carotene treatment on cardiac function in isolated 
hearts subjected to I/R 
No BC-mediated effects on AF were observed in hearts not 
subjected to REP, however, relative to hearts from vehicle-treated control 
animals, hearts from animals subjected to 30 min of ISA followed by 30 and 
60 min of REP exhibited significantly increased AF when taken from rats 
treated with LD–BC (p<0,05); but interestingly, not which were subjected 
to 120 min of REP or from those fed with HD-BC. No significant BC 
dosage effects on CF were observed in non-reperfused hearts, or in hearts 
from animals subjected to 30 min of I/R. Furthermore, HD–BC treatment 
resulted in a significant increase on CF values after 60 and 120 min of REP 
relative to organs from non BC-treated controls (p<0.05). Likewise CO in 
non-ISA/REP hearts and those subjected to 120 min of REP did not vary 
significantly as a result of BC treatment, where as significant CO increases 
in these hearts relative to organs from non-BC-treated controls were 
observed in those sustaining reperfusion periods of 30 min (p<0.05) and 60 
min (p<0.05) from rats receiving 30 mg/kg/day BC, but not 150 mg/kg/day 
of the agent. Treatment of animals with 150 mg/kg/day BC resulted in 
significant increase in HR for I/R hearts (p<0.05). Evaluation of the effects 
of BC on heart SV, revealed no significant BC effect on this variable in non 
I/R hearts, or organs subjected to I/R. It was further noted that SV values in 
hearts receiving 30 and 60 min of REP from animals treated with 150 
mg/kg/day BC were reduced; however it was not significant, relative to 
those from rats receiving low BC dose. This apparent loss of cardio 
protection at elevated BC dosage was further confirmed by measurement of 
stroke volume decline (dSV). These results demonstrated that relative to 
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non I/R hearts, hearts subjected to 30 and 60, but not 120 min of REP 
exhibited lesser declines in stroke volume when taken from animals treated 
with 30 mg/kg/day BC than from rats receiving 0 or 150 mg/kg/day BC; 
however, it did not reach the significant level.  
Effects of beta-carotene treatment on I/R-induced infarct size and 
tissue antioxidant capacity (TAC) 
Macroscopic analysis of TTC solution perfused heart sections from 
rats subjected to 30 min of global ISA followed by 120 min of REP in a 
“working-heart” apparatus revealed that LD–BC treatment, correlated with 
significant reduction of the extent of infarcted myocardium relative to the 
control values (p<0.05). This protective effect is abolished in hearts taken 
from animals treated with high-dose BC (p<0.05). The phenomenon of 
diminished BC-mediated protective effect on cardiac physiology was also 
dramatically illustrated in outcomes of experiments to assess contribution of 
the agent to tissue antioxidant capacity (TAC), a process that has evolved as 
a homeostatic countermeasure to oxidative stress. The isolated, I/R injured 
working hearts taken from rats administered LD–BC, exhibited TAC values 
significantly in excess of vehicle-treated controls (p<0.05) and hearts 
isolated from HD–BC treated animals (p<0.05). Nevertheless, TAC values 
measured in hearts from animals received HD–BC were not significantly 
higher, that hearts from control rats received vehicle.  
Effects of beta-carotene on heme oxygenase-1 (HO-1) protein 
expression 
Hearts excised from the animals were either sham treated         
(BL-baseline), or I/R injured (I/R) by 30 min of global ISA and 120 min of 
REP. The results show that in control hearts which were not subjected to I/R 
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(C-BL) HO-1 expression was not significantly different from non injured 
hearts removed from rats receiving LD–BC (LD–BL), while high dose 
treatment (HD–BL) resulted in significantly increased HO-1 level (p<0.05). 
Production of HO-1 protein in I/R injured hearts from rats fed with either 
low dose (LD-I/R) or high dose BC (HD-I/R), was significantly higher 
compared to non treated non injured (C-BL) group (p<0.05). Moreover, 
HO-1 expression in hearts removed from vehicle treated animals and 
subjected to I/R (C-I/R) was not significantly different from hearts excised 
from rats receiving LD–BC and subjected to I/R (LD-I/R); however, hearts 
from high-dose treated animals expressed significantly elevated levels of 
HO-1 protein relative to corresponding levels measured in vehicle treated 
controls (C-I/R) (p<0.05).  
MTT assay-based evaluation of beta-carotene cytotoxicity  
Significant increases in H9c2 cell viability challanged by H2O2 was 
observed in cultures of these cells grown 24 h in Dulbecco’s medium 
supplemented with 2.5, 5 and 10 µM BC, relative to cells grown with no BC 
added (p<0.05). Furthermore, this protective effect was not observed in 
cells treated with 20 µM of BC. 
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4. Summary 
The devastating health statistics of Hungary and the World are 
sufficient reason to humans to change their lifestyle. Cardiovascular 
diseases are leading cause of death worldwide and obesity is one of its main 
risk factor. In these conditions body suffers from continuously elevated 
oxidative stress. Nowadays, there is a growing demand for prevention and 
supplementary therapy besides to the medical treatment of an existing 
disease. Substances with natural origin are able to fulfill the requirements 
due to their favorable toxicological and side effect profile. 
We have studied the toxicological profile of sour cherry seed in a 
mouse model. No sign of liver and kidney toxicity were found during the 
experiments. Moreover, we have examined the photo protective properties 
of creams containing sour cherry seed oil in different concentration in 
Guinea pig model. Our results demonstrated that sour cherry seed oil 
possesses photo protective effect.  
We have investigated the effect of low versus high dose beta-
carotene treatment using rat model. The low-dose pretreatment resulted in 
cardioprotection evidenced by recovery of postischemic heart functions, 
decreased infarct size, not significantly but increased HO-1 enzyme 
expression and elevated tissue antioxidant capacity. In high dose treated we 
failed to observe any protection on the heart.  
 Outcomes of our research may contribute to use in 
prevention both materials with natural origin, as well as to extend the 
scientific knowledge related to them. 
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